139 related articles for article (PubMed ID: 18570599)
1. The effects of fexofenadine at steady-state on sleep architecture: a study using polysomnography in healthy Korean volunteers.
Lee HW; Lee HW; Park DJ; Moon SO; Ahn JH; Kim MJ; Kim SD; Kim JE; Yoon YR
Expert Opin Pharmacother; 2008 Jul; 9(10):1655-65. PubMed ID: 18570599
[TBL] [Abstract][Full Text] [Related]
2. Allergy medication in Japanese volunteers: treatment effect of single doses on nocturnal sleep architecture and next day residual effects.
Boyle J; Eriksson M; Stanley N; Fujita T; Kumagi Y
Curr Med Res Opin; 2006 Jul; 22(7):1343-51. PubMed ID: 16834833
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology of H1-antihistamines in the skin.
Simons FE; Silver NA; Gu X; Simons KJ
J Allergy Clin Immunol; 2002 Nov; 110(5):777-83. PubMed ID: 12417888
[TBL] [Abstract][Full Text] [Related]
4. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism.
Shon JH; Yoon YR; Hong WS; Nguyen PM; Lee SS; Choi YG; Cha IJ; Shin JG
Clin Pharmacol Ther; 2005 Aug; 78(2):191-201. PubMed ID: 16084853
[TBL] [Abstract][Full Text] [Related]
5. Dose proportionality and comparison of single and multiple dose pharmacokinetics of fexofenadine (MDL 16455) and its enantiomers in healthy male volunteers.
Robbins DK; Castles MA; Pack DJ; Bhargava VO; Weir SJ
Biopharm Drug Dispos; 1998 Oct; 19(7):455-63. PubMed ID: 9818712
[TBL] [Abstract][Full Text] [Related]
6. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
[TBL] [Abstract][Full Text] [Related]
7. Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein.
Shimizu M; Uno T; Sugawara K; Tateishi T
Br J Clin Pharmacol; 2006 May; 61(5):538-44. PubMed ID: 16669847
[TBL] [Abstract][Full Text] [Related]
8. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
Yi SY; Hong KS; Lim HS; Chung JY; Oh DS; Kim JR; Jung HR; Cho JY; Yu KS; Jang IJ; Shin SG
Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
[TBL] [Abstract][Full Text] [Related]
9. Characterization of daytime sleepiness and psychomotor performance following H1 receptor antagonists.
Witek TJ; Canestrari DA; Miller RD; Yang JY; Riker DK
Ann Allergy Asthma Immunol; 1995 May; 74(5):419-26. PubMed ID: 7749974
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of acute effects of single doses of fexofenadine, olopatadine, d-chlorpheniramine and placebo on psychomotor function in healthy volunteers.
Kamei H; Noda Y; Ishikawa K; Senzaki K; Muraoka I; Hasegawa Y; Hindmarch I; Nabeshima T
Hum Psychopharmacol; 2003 Dec; 18(8):611-8. PubMed ID: 14696020
[TBL] [Abstract][Full Text] [Related]
11. Antihistamines and aircrew: usefulness of fexofenadine.
Nicholson AN; Stone BM; Turner C; Mills SL
Aviat Space Environ Med; 2000 Jan; 71(1):2-6. PubMed ID: 10632124
[TBL] [Abstract][Full Text] [Related]
12. The effects of acute doses of fexofenadine, promethazine, and placebo on cognitive and psychomotor function in healthy Japanese volunteers.
Ridout F; Hindmarch I
Ann Allergy Asthma Immunol; 2003 Apr; 90(4):404-10. PubMed ID: 12722962
[TBL] [Abstract][Full Text] [Related]
13. MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine.
Drescher S; Schaeffeler E; Hitzl M; Hofmann U; Schwab M; Brinkmann U; Eichelbaum M; Fromm MF
Br J Clin Pharmacol; 2002 May; 53(5):526-34. PubMed ID: 11994059
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers.
Russell T; Stoltz M; Weir S
Clin Pharmacol Ther; 1998 Dec; 64(6):612-21. PubMed ID: 9871426
[TBL] [Abstract][Full Text] [Related]
15. Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers.
Boyle J; Ridout F; Meadows R; Johnsen S; Hindmarch I
Curr Med Res Opin; 2005 Sep; 21(9):1495-503. PubMed ID: 16197669
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers.
Hindmarch I; Shamsi Z; Kimber S
Clin Exp Allergy; 2002 Jan; 32(1):133-9. PubMed ID: 12002730
[TBL] [Abstract][Full Text] [Related]
17. Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment.
Olsén L; Ingvast-Larsson C; Larsson P; Broström H; Bondesson U; Sundqvist M; Tjälve H
J Vet Pharmacol Ther; 2006 Apr; 29(2):129-35. PubMed ID: 16515667
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the histamine wheal by ebastine compared with cetirizine, fexofenadine and loratadine at steady state.
Carey W; Warrington S; Boyce M; Luria X
Drugs Exp Clin Res; 2002; 28(6):243-7. PubMed ID: 12776578
[TBL] [Abstract][Full Text] [Related]
19. The H1 histamine receptor blocker, chlorpheniramine, completely prevents the increase in REM sleep induced by immobilization stress in rats.
Rojas-Zamorano JA; Esqueda-Leon E; Jimenez-Anguiano A; Cintra-McGlone L; Mendoza Melendez MA; Velazquez Moctezuma J
Pharmacol Biochem Behav; 2009 Jan; 91(3):291-4. PubMed ID: 18700151
[TBL] [Abstract][Full Text] [Related]
20. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
